Related Molecular Mechanisms of Glucagon-Like Peptide-1 Receptor Agonists in Osteoporosis Glucagon-Like Peptide-1 Receptor/cAMP/PI3K/AKT Signal Pathway The PI3K/AKT signaling pathway plays an important role in regulating proliferation, osteoblast differentiation and osteoclast differentiation, apoptosis (Figure 1)
Beyond obvious effects on energy balance, dietary quality can also influence obesity risk through changes in metabolic adaptation due to a high refined carbohydrate diet, in resting energy expenditure (such as through brown or beige adipose tissue thermogenesis), in microbiome calorie utilization (with corresponding greater or lesser utilization by the host tissues), and in epigenetic or trans -generational risk of obesity [81,82]
The field is actively investigating whether longer-acting agents will show different results
GLP-1 drugs are indicated for patients with BMI above 25 even without complications, or BMI above 23 with obesity-related conditions such as diabetes, hypertension, or fatty liver disease
Some may also hope that weight-loss results will be sustained without it
The first wave will hopefully be the approval of more small-molecule GLP-1RAs